ATOSSA THERAPEUTICS, INC. Earnings Per Share (Basic)
ATOSSA THERAPEUTICS, INC. (ATOS) reported Earnings Per Share (Basic) of -$0.95 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.95.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$1.11.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.07.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.98.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$4.04.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$3.04.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$0.24.
- ATOSSA THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$0.21.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.95 10-Q · filed 2026-08-07 | -$2.06 10-Q · filed 2026-08-07 | |||||
| 2026-03-31 | -$1.11 10-Q · filed 2026-05-08 | ||||||
| 2025-12-31 | -$4.04 10-K · filed 2026-03-25 | ||||||
| 2025-09-30 | -$0.07 10-Q · filed 2025-11-12 | -$0.18 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | -$0.98 10-Q · filed 2026-08-07 | -$0.07 10-Q · filed 2025-08-12 | -$1.76 10-Q · filed 2026-08-07 | -$0.12 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | -$0.78 10-Q · filed 2026-05-08 | -$0.05 10-Q · filed 2025-05-13 | |||||
| 2024-12-31 | -$3.04 10-K · filed 2026-03-25 | -$0.20 10-K · filed 2025-03-25 | |||||
| 2024-09-30 | -$0.06 10-Q · filed 2025-11-12 | -$0.15 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | -$0.05 10-Q · filed 2025-08-12 | -$0.10 10-Q · filed 2025-08-12 | |||||
| 2024-03-31 | -$0.05 10-Q · filed 2025-05-13 | ||||||
| 2023-12-31 | -$0.24 10-K · filed 2025-03-25 | ||||||
| 2023-09-30 | -$0.05 10-Q · filed 2024-11-12 | -$0.18 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | -$0.08 10-Q · filed 2024-08-12 | -$0.13 10-Q · filed 2024-08-12 | |||||
| 2023-03-31 | -$0.05 10-Q · filed 2024-05-13 | ||||||
| 2022-12-31 | -$0.21 10-K · filed 2024-04-01 | ||||||
| 2022-09-30 | -$0.06 10-Q · filed 2023-11-13 | -$0.12 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.15 10-Q · filed 2023-11-13 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-11-13 | |||
| 2022-06-30 | -$0.05 10-Q · filed 2023-08-14 | -$0.09 10-Q · filed 2023-08-14 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$0.17 derived: net income ÷ weighted average shares · filed 2023-08-14 | |||
| 2022-03-31 | -$0.04 10-Q · filed 2023-05-15 | -$0.08 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$0.12 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$0.17 derived: net income ÷ weighted average shares · filed 2023-05-15 | |||
| 2021-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$0.08 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$0.14 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$0.18 10-K · filed 2023-03-22 | |||
| 2021-09-30 | -$0.04 10-Q · filed 2022-11-07 | -$0.10 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$0.14 10-Q · filed 2022-11-07 | ||||
| 2021-06-30 | -$0.06 10-Q · filed 2022-08-08 | -$0.10 10-Q · filed 2022-08-08 | |||||
| 2021-03-31 | -$0.04 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |